Search

everythinglearnresearchcommunity

for

Search:↓

Hair conditions can be linked to diabetes and affect psychological health.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

HIV-positive pregnant women are more likely to experience severe bleeding, and a pregnant woman with familial hypertriglyceridemia had a successful early delivery with special care.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Recognizing and treating early signs of insulin resistance can help prevent type 2 diabetes and improve life quality.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

Female pattern hair loss is more common among Indian women than previously believed.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Dihydrotestosterone increases arterial stiffness in female mice without changing blood pressure or aortic wall thickness.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Only 22% of teenage girls in the study knew about PCOS, despite many having symptoms.

PCOS is linked to metabolic issues and infertility, needing more research.

Hair loss linked to higher heart disease risk in both men and women.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Hair loss may indicate higher heart risk and metabolic issues.

New treatments for PCOS focus on managing symptoms and improving fertility.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Finasteride helps induce ovulation in nonresponder PCOS women.